AELIX announces ‘important step towards HIV eradication’
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
Beckley Psytech Ltd has received investigational new drug (IND) approval from the U.S. Food and…
Modus Therapeutics AB has published positive top-line data from its phase 1b lipopolysaccharide (LPS) provocation…
Pharming Group N.V. says the first patient has been enrolled in its phase III clinical…
INOVIO Pharmaceuticals has announced positive preliminary results from the second cohort of its phase 1/2…
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park,…
Novotech, an Asia Pacific biotech CRO, has published a new global report on phase 1…
Newron Pharmaceuticals S.p.A. has announced what it says are ‘very exciting new results’ from the…
UroGen Pharma Ltd. has announced preliminary results of a study to assess the feasibility of…
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…
Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead…